Clinical Trial Update: An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports on the Phase 1/2 efficacy and safety study of HGT-1110 in participants with Metachromatic Leukodystrophy (MLD). The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metachromatic Leukodystrophy

Drugs mentioned

• HGT-1110

Snippet

Sponsor: Shire | Conditions: Metachromatic Leukodystrophy (MLD) | Phase 1, Phase 2 | Status: COMPLETED